We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$6.16M
Cap. Flow
-$15.9M
Cap. Flow %
-9.4%
Top 10 Hldgs %
30.18%
Holding
221
New
53
Increased
41
Reduced
35
Closed
49

Top Buys

Rank Stock Value
1
CMBM
Cambium Networks
CMBM
+$2.89M
2
INDI icon
indie Semiconductor
INDI
+$2.88M
3
ASPN icon
Aspen Aerogels
ASPN
+$2.86M
4
SCPH
scPharmaceuticals
SCPH
+$2.68M
5
BDSX icon
Biodesix
BDSX
+$2.04M

Top Sells

Rank Stock Value
1
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$7.12M
2
MTRN icon
Materion
MTRN
+$4.81M
3
SEV
Sono Group N.V. Common Shares
SEV
+$2.22M
4
SIMO icon
Silicon Motion
SIMO
+$1.88M
5
TTGT icon
TechTarget
TTGT
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 21.33%
3 Financials 6.11%
4 Industrials 3.63%
5 Real Estate 3.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOL icon
176
Toll Brothers
TOL
$14.1B
– –
-6,800
Closed -$286K
TTGT icon
177
TechTarget
TTGT
$323M
– –
-17,742
Closed -$1.05M
VGK icon
178
PUT
Vanguard FTSE Europe ETF
VGK
$30.8B
– –
-21,400
Closed -$83K
X
179
PUT
DELISTED
US Steel
X
– –
-44,600
Closed -$30K
XFOR icon
180
X4 Pharmaceuticals
XFOR
$386M
– –
-8,338
Closed -$428K
XLV icon
181
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
– –
-13,400
Closed -$15K
NBSE
182
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
– –
-10,602
Closed -$84K
FSR
183
PUT
DELISTED
Fisker Inc.
FSR
– –
-10,300
Closed -$5K
SUNW
184
DELISTED
Sunworks, Inc.
SUNW
– –
-15,000
Closed -$42K
ICPT
185
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-93,700
Closed -$8K
SEV
186
DELISTED
Sono Group N.V. Common Shares
SEV
– –
-874,813
Closed -$2.22M
ATCO
187
PUT
DELISTED
Atlas Corp.
ATCO
– –
-12,500
Closed -$4K
ATNX
188
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-12,442
Closed -$67K
TCDA
189
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-26,800
Closed -$38K
TCDA
190
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-23,800
Closed -$249K
TCDA
191
PUT
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-66,500
Closed -$123K
HZNP
192
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-13,400
Closed -$829K
HZNP
193
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-16,800
Closed -$9K
4 5 6 7
8

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Worth Venture Partners held 221 positions worth $169M, up 3.8% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Worth Venture Partners withdrew a net $15.9M in Q4 2022, closing 49 positions and reducing 35 holdings. Its most notable exit was Materion, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Cambium Networks worth $3.11M.

  • Worth Venture Partners's largest Q4 2022 buy was Cambium Networks: 143,499 shares worth $3.11M.
  • Worth Venture Partners added most to indie Semiconductor in Q4 2022, an estimated $2.88M increase.
  • Worth Venture Partners's biggest Q4 2022 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $7.12M.
  • Worth Venture Partners fully exited Materion in Q4 2022, selling an estimated $4.81M.
  • Worth Venture Partners's ten largest holdings make up 30% of its $169M portfolio in Q4 2022.
  • Worth Venture Partners opened 53 new positions and closed 49 in Q4 2022.
  • Worth Venture Partners's portfolio value rose 3.8% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q4 2022, filed 14 Feb 2023.